Literature DB >> 8621023

Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects.

S J Hunter1, A B Atkinson, C N Ennis, B Sheridan, P M Bell.   

Abstract

Abnormalities of both insulin secretion and insulin action occur in NIDDM. It is not clear, however, which is the primary defect. Recently, it has been suggested that the frequency of insulin pulses is an important factor regulating insulin action in normal humans. We examined the relationship between pulsatile insulin secretion and insulin action in eight NIDDM subjects and eight health matched control subjects. Insulin action was assessed prevailing fasting glucose levels before and after hype insulinemia (2-h insulin infusion at 2.0 mU / kg / min). Pulsatility of insulin was assessed by sampling every 2 min for 90 min after an overnight fast and identifying insulin pulses using the computer program Pulsar. Fasting plasma glucose and postabsorptive endogenous glucose production were both greater in diabetic subjects compared with control subjects (10.1 +/- 1.2 vs. 5.4 +/- 0.1 mmol/l, P < 0.01; 11.8 +/- 0.8 vs. 9.9 +/- 0.4 micromol / kg / min, P < 0.05). During the 2.0 mU insulin infusion, glucose clearance was lower in the diabetic subjects (3.6 +/- 0.7 vs. 6.9 +/- 0.5 ml / kg / min), P < 0.05), whereas endogenous glucose production was suppressed to a similar degree in both groups (4.5 +/- 0.8 vs. 3.6 +/- 0.7 micromol x kg(-1) x min(-1), NS). The frequency of insulin pulses and glucose clearance were negatively correlated in both diabetic subjects (r = -0.75, P < 0.05) and normal control subjects (r = -0.82, P < 0.01). This negative correlation was also present in both groups taken together (r = -0.72, P < 0.001). There was no correlation between insulin pulse frequency and endogenous glucose production either in the fasting state or during hyperinsulinemia. We concluded that the frequency of insulin pulses and peripheral insulin sensitivity are closely linked in NIDDM and normal subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621023     DOI: 10.2337/diab.45.5.683

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

Review 1.  Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.

Authors:  Leslie S Satin; Peter C Butler; Joon Ha; Arthur S Sherman
Journal:  Mol Aspects Med       Date:  2015-01-28

2.  Insulin Pulse Characteristics and Insulin Action in Non-diabetic Humans.

Authors:  Marcello C Laurenti; Chiara Dalla Man; Ron T Varghese; James C Andrews; John G Jones; Cristina Barosa; Robert A Rizza; Aleksey Matveyenko; Giuseppe De Nicolao; Kent R Bailey; Claudio Cobelli; Adrian Vella
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

Review 3.  Effects of Periodic Intensive Insulin Therapy: An Updated Review.

Authors:  Shu Dong; Hien Lau; Cody Chavarria; Michael Alexander; Allison Cimler; John P Elliott; Sandra Escovar; Jack Lewin; James Novak; Jonathan R T Lakey
Journal:  Curr Ther Res Clin Exp       Date:  2019-04-30

4.  Type 2 Diabetes-Associated K+ Channel TALK-1 Modulates β-Cell Electrical Excitability, Second-Phase Insulin Secretion, and Glucose Homeostasis.

Authors:  Nicholas C Vierra; Prasanna K Dadi; Imju Jeong; Matthew Dickerson; David R Powell; David A Jacobson
Journal:  Diabetes       Date:  2015-08-03       Impact factor: 9.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.